Bristol-Myers Squibb's total assets for Q4 2024 were $92.60B, a decrease of -1.14% from the previous quarter. BMY total liabilities were $76.22B for the fiscal quarter, a -0.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.